Awaiting development: Guidance and quality standards
Showing 1 to 2 of 2
| Title | Type |
|---|---|
| Doravirine-islatravir for previously untreated HIV-1 infection | Technology appraisal guidance |
| Pritelivir (AIC-316) for Herpes simplex virus 2 infection (HSV-2) [12367] | Technology appraisal guidance |